Current processes of the U.S. Preventive Services Task Force: Refining evidence-based recommendation development

U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland, USA.
Annals of internal medicine (Impact Factor: 17.81). 08/2007; 147(2):117-22. DOI: 10.7326/0003-4819-147-2-200707170-00170
Source: PubMed


The U.S. Preventive Services Task Force (USPSTF), an independent panel that has provided the gold standard for evidence-based guidelines in prevention for the past 2 decades, continuously refines its methodology. To keep up with the evolving field of evidence- based medicine and to update recommendations in a timely, efficient, and transparent manner, the USPSTF has developed new methods for evidence reviews and recommendation development. This article summarizes the most recent changes in the recommendation development process, including how the USPSTF solicits and prioritizes topics for review, updates evidence reviews and recommendations, and communicates with its audience.

Download full-text


Available from: Evelyn P Whitlock, Oct 06, 2015
108 Reads
  • Source
    • "A meta-analysis is a statistical analysis to combine results across multiple, similar studies, and is usually undertaken within the context of a systematic review. Systematic reviews and meta-analyses are widely used in evidence-based health care to develop clinical and public health practice guidelines (Guirguis-Blake et al., 2007; WHO, 2010), set research priorities (NICE, 2009; Rylance et al., 2010), formulate scientific consensus statements (ADA, 2012) and in health technology assessments (Busse et al., 2002). Unlike traditional (narrative) reviews, systematic reviews follow an explicit process that aims to minimize bias and maximize transparency, thus providing more reliable and documentable findings from which conclusions can be drawn and decisions made (Higgins and Green, 2011). "
  • Source
    • "At an Institute of Medicine workshop, Fran Visco, president of NBCC, criticized the USPSTF’s communication and dissemination strategies outlined in a 2007 report [15]. She said: "
    [Show abstract] [Hide abstract]
    ABSTRACT: Health care news stories have the potential to inform and educate news consumers and health-care consumers about the tradeoffs involved in health-care decisions about treatments, tests, products, and procedures. These stories have the potential to influence not only individual decision making but also the broader public dialogue about health-care reform. For the past 7 years, a Web-based project called has evaluated news stories to try to improve health-care journalism and the quality and flow of information to consumers. applies 10 standardized criteria to the review of news stories that include claims about medical interventions. Two or three reviewers evaluate each story. The team has evaluated more than 1,800 stories by more than a dozen leading U.S. news organizations. About 70% have received unsatisfactory scores based on application of these criteria: reporting on costs, quantifying potential benefits, and quantifying potential harms. Inaccurate, imbalanced, incomplete news stories may drown out more careful scrutiny of the evidence by many influential news organizations. Unquestioned claims and assertions about the benefits of medical interventions are passed on to the American public daily by journalists who are supposed to vet independently any such claims. Communication about these issues is, in itself, a major health-policy issue.
    BMC Medical Informatics and Decision Making 12/2013; 13 Suppl 3(Suppl 3):S3. DOI:10.1186/1472-6947-13-S3-S3 · 1.83 Impact Factor
  • Source
    • "First, with regard to the creation of centrally managed repositories of computer-processable medical knowledge, methods for generating authoritative knowledge on the appropriate use of genetics and genomics in clinical medicine have been developed by groups including the U.S. Preventive Services Task Force [44], which is sponsored by the U.S. Agency for Healthcare Research and Quality (AHRQ), and by the Evaluation of Genomic Applications in Practice and Prevention initiative [45], which is sponsored by the U.S. Centers for Disease Control and Prevention (CDC). These efforts and their associated methodologies could be applied systematically to emerging genetic and genomic interventions to provide definitive guidance on how they should be used in practice. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In recent years, the completion of the Human Genome Project and other rapid advances in genomics have led to increasing anticipation of an era of genomic and personalized medicine, in which an individual's health is optimized through the use of all available patient data, including data on the individual's genome and its downstream products. Genomic and personalized medicine could transform healthcare systems and catalyze significant reductions in morbidity, mortality, and overall healthcare costs. Critical to the achievement of more efficient and effective healthcare enabled by genomics is the establishment of a robust, nationwide clinical decision support infrastructure that assists clinicians in their use of genomic assays to guide disease prevention, diagnosis, and therapy. Requisite components of this infrastructure include the standardized representation of genomic and non-genomic patient data across health information systems; centrally managed repositories of computer-processable medical knowledge; and standardized approaches for applying these knowledge resources against patient data to generate and deliver patient-specific care recommendations. Here, we provide recommendations for establishing a national decision support infrastructure for genomic and personalized medicine that fulfills these needs, leverages existing resources, and is aligned with the Roadmap for National Action on Clinical Decision Support commissioned by the U.S. Office of the National Coordinator for Health Information Technology. Critical to the establishment of this infrastructure will be strong leadership and substantial funding from the federal government. A national clinical decision support infrastructure will be required for reaping the full benefits of genomic and personalized medicine. Essential components of this infrastructure include standards for data representation; centrally managed knowledge repositories; and standardized approaches for leveraging these knowledge repositories to generate patient-specific care recommendations at the point of care.
    BMC Medical Informatics and Decision Making 02/2009; 9(1):17. DOI:10.1186/1472-6947-9-17 · 1.83 Impact Factor
Show more